title: Downregulation of microRNA-383 is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation by targeting IRF1.
abstract: Our previous studies have shown that microRNA-383 (miR-383) expression is downregulated in the testes of infertile men with maturation arrest (MA). However, the underlying mechanisms of miR-383 involved in the pathogenesis of MA remain unknown. In this study, we showed that downregulation of miR-383 was associated with hyperactive proliferation of germ cells in patients with mixed patterns of MA. Overexpression of miR-383 in NT2 (testicular embryonal carcinoma) cells resulted in suppression of proliferation, G1-phase arrest and induction of apoptosis, whereas silencing of miR-383 reversed these effects. The effects of miR-383 were mediated through targeting a tumor suppressor, interferon regulatory factor-1 (IRF1), and miR-383 was negatively correlated with IRF1 protein expression in vivo. miR-383 inhibited IRF1 by affecting its mRNA stability, which subsequently reduced the levels of the targets of IRF1, namely cyclin D1, CDK2 and p21. Downregulation of IRF1 or cyclin D1, but not that of CDK2, enhanced miR-383-mediated effects, whereas silencing of p21 partially inhibited the effects of miR-383. Moreover, miR-383 downregulated CDK4 by increasing proteasome-dependent degradation of CDK4, which in turn resulted in an inhibition of phosphorylated retinoblastoma protein (pRb) phosphorylation. These results suggest that miR-383 functions as a negative regulator of proliferation by targeting IRF1, in part, through inactivation of the pRb pathway. Abnormal testicular miR-383 expression may potentiate the connections between male infertility and testicular germ cell tumor.
authors.affiliation: Hefei National Laboratory for Physical Sciences, Microscale and School of Life Sciences, University of Science and Technology of China, Anhui, China.
authors.forename: J
authors.initials: J
authors.lastname: Lian
authors.forename: H
authors.initials: H
authors.lastname: Tian
authors.forename: L
authors.initials: L
authors.lastname: Liu
authors.forename: X-S
authors.initials: XS
authors.lastname: Zhang
authors.forename: W-Q
authors.initials: WQ
authors.lastname: Li
authors.forename: Y-M
authors.initials: YM
authors.lastname: Deng
authors.forename: G-D
authors.initials: GD
authors.lastname: Yao
authors.forename: M-M
authors.initials: MM
authors.lastname: Yin
authors.forename: F
authors.initials: F
authors.lastname: Sun
mesh_terms: D000818:Animals; D017209:Apoptosis; D018236:Carcinoma, Embryonal / Q000235:genetics*; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D019938:Cyclin D1 / Q000378:metabolism; D051357:Cyclin-Dependent Kinase 2 / Q000378:metabolism; D051358:Cyclin-Dependent Kinase 4 / Q000378:metabolism; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000378:metabolism; D015536:Down-Regulation; D054278:Embryonal Carcinoma Stem Cells / Q000166:cytology; D016193:G1 Phase; D006801:Humans; D007248:Infertility, Male / Q000235:genetics* / Q000378:metabolism; D050856:Interferon Regulatory Factor-1 / Q000235:genetics* / Q000378:metabolism; D008297:Male; D051379:Mice; D035683:MicroRNAs / Q000378:metabolism*; D010766:Phosphorylation; D016160:Retinoblastoma Protein / Q000378:metabolism; D013736:Testicular Neoplasms / Q000235:genetics*
chemical_list: D050759:Cyclin-Dependent Kinase Inhibitor p21; C494257:IRF1 protein, human; D050856:Interferon Regulatory Factor-1; C558685:MIRN383 microRNA, human; D035683:MicroRNAs; D016160:Retinoblastoma Protein; D019938:Cyclin D1; D051357:Cyclin-Dependent Kinase 2; D051358:Cyclin-Dependent Kinase 4